PROVIDER PROFILE · NPI 1053688671
Sergelyne Cadet-Valeus
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
5,313
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
88
Brand share
35.0%
Top prescribed drugs
Atorvastatin Calcium459 claims
Amlodipine Besylate270 claims
Metformin Hcl261 claims
Losartan Potassium201 claims
Omeprazole148 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$1K
Payment records
47
By payment type
Food and Beverage$1K
Top paying entities
Food and Beverage$1K
REFERRAL NETWORK
Where Sergelyne Cadet-Valeus's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| JOSEPH P. ADDABBO FAMILY HEALTH CENTER, INC. | 27 | 66 |
| EPISCOPAL HEALTH SERVICES INC | 16 | 32 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| JOSEPH P. ADDABBO FAMILY HEALTH CENTER, INC. | 56 | 199 |
| Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ | 36 | 67 |
| EPISCOPAL HEALTH SERVICES INC | 22 | 72 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE